ANTICONVULSANT DRUG TOXICITYWILDER BJ.1978; CLIN. NEUROPHARMACOL.; USA; DA. 1978; VOL. 3; PP. 57-84; BIBL. 7 P.Article

REVERSE PHASE LIQUID CHROMATOGRAPHY AT INCREASED TEMPERATUREPERCHALSKI RJ; WILDER BJ.1979; ANAL. CHEM.; USA; DA. 1979; VOL. 51; NO 6; PP. 774-776; BIBL. 1 REF.Article

EFFECTS OF ANTICONVULSANT DRUGS ON ENFLURANE CORTICAL DYSRHYTHMIAS = EFFETS DES ANTICONVULSIVANTS SUR LES DYSRYTHMIES CORTICALES PROVOQUEES PAR L'ENFLURANESCHETTINI A; WILDER BJ.1974; ANESTH. AND ANALG.; U.S.A.; DA. 1974; VOL. 53; NO 6; PP. 951-962; BIBL. 25REF.Article

INTRAMUSCULAR ADMINISTRATION OF DIPHENYLDANTOIN. HISTOLOGIC FOLLOW-UP STUDIES = ADMINISTRATION INTRAMUSCULAIRE DE DIPHENYLHYDANTOINE. ETUDE HISTOLOGIQUE LONGITUDINALESERRANO EE; WILDER BJ.1974; ARCH. NEUROL.; U.S.A.; DA. 1974; VOL. 31; NO 4; PP. 276-278; BIBL. 6REF.Article

EVOKED POTENTIALS IN OLIVOPONTOCEREBELLAR ATROPHYHAMMOND EJ; WILDER BJ.1983; ARCHIVES OF NEUROLOGY (CHICAGO); ISSN 0003-9942; USA; DA. 1983; VOL. 40; NO 6; PP. 366-369; BIBL. 19 REF.Article

IMMUNOFLUORESCENT EVIDENCE FOR A SPECIFIC BINDING SITE FOR PHENYTOIN IN THE CEREBELLUMHAMMOND EJ; WILDER BJ.1983; EPILEPSIA; ISSN 0013-9580; NLD; DA. 1983; VOL. 24; NO 3; PP. 269-274; ABS. SPA/GER; BIBL. 2 P.Article

METHSUXIMIDE FOR REFRACTORY COMPLEX PARTIAL SEIZURESWILDER BJ; BUCHANAN RA.1981; NEUROLOGY; ISSN 0028-3878; USA; DA. 1981; VOL. 31; NO 6; PP. 741-744; BIBL. 11 REF.Article

DETERMINATION OF BENZODIAZEPINE ANTICONVULSANTS IN PLASMA BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.PARCHALSKI RJ; WILDER BJ.1978; ANAL. CHEM.; U.S.A.; DA. 1978; VOL. 50; NO 4; PP. 554-557; BIBL. 11 REF.Article

ORAL AND INTRAMUSCULAR PHENYTOINWILDER BJ; RAMSAY RE.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 3; PP. 360-364; BIBL. 10 REF.Article

HOMOCYSTEINE INDUCED CONVULSIONS: ENHANCEMENT BY VITAMIN B₆ AND INHIBITION BY HYDRAZINEHURD RW; HAMMOND EJ; WILDER BJ et al.1981; BRAIN RES.; ISSN 0006-8993; NLD; DA. 1981; VOL. 209; NO 1; PP. 250-254; BIBL. 25 REF.Article

FLAME-IONIZATION AND ELECTRON-CAPTURE GLC DETERMINATION OF 1-(2,6-DIMETHYLPHENOXY)-2-AMINOPROPANE IN PLASMA = DETERMINATION PAR CHROMATOGRAPHIE EN PHASE GAZEUSE AVEC IONISATION DE FLAMME ET CAPTURE D'ELECTRONS DE LA (DIMETHOXY-2,6 PHENOXY)-1 AMINO-2 PROPANE DANS LE PLASMAPERCHALSKI RJ; WILDER BJ; HAMMER RH et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 9; PP. 1489-1491; BIBL. 4REF.Article

EFFECT OF PHENYTOIN ON PROTEIN BINDING OF VALPROIC ACIDBRUNI J; GALLO JM; WILDER BJ et al.1979; CANAD. J. NEUROL. SCI.; CAN; DA. 1979; VOL. 6; NO 4; PP. 453-454; BIBL. 11 REF.Article

EVALUATION OF EIMAC LAMP AS EXCITATION SOURCE FOR MOLECULAR FLUORESCENCE WITH APPLICATION TO QUANTITATION OF ERGOTAMININE IN PLASMA BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY.PERCHALSKI RJ; WINEFORDNER JD; WILDER BJ et al.1975; ANAL. CHEM.; U.S.A.; DA. 1975; VOL. 47; NO 12; PP. 1993-1999; BIBL. 43 REF.Article

CENTRAL ACTIONS OF VALPROIC ACID IN MAN AND IN EXPERIMENTAL MODELS OF EPILEPSYHAMMOND EJ; WILDER BJ; BRUNI J et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 29; NO 25; PP. 2561-2574; BIBL. 92 REF.Article

A METHOD OF MODIFYING THE RAPIDITY OF COBALT-INDUCED EPILEPTOGENESIS IN THE CAT = METHODE DE MODIFICATION DE L'ACTION EPILEPTOGENE RAPIDE DU CO METALLIQUE CHEZ LE CHATMALZONE WF; WILDER BJ; MAYERSDORF A et al.1972; EPILEPSIA; PAYS-BAS; DA. 1972; VOL. 13; NO 5; PP. 643-648; ABS. FR.; BIBL. 5REF.Serial Issue

CLINICAL EFFICACY AND LONG-TERM EFFECTS OF VALPROIC ACID THERAPY ON SPIKE-AND-WAVE DISCHARGESBRUNI J; WILDER BJ; BAUMAN AW et al.1980; NEUROLOGY; USA; DA. 1980; VOL. 30; NO 1; PP. 42-46; BIBL. 15 REF.Article

GASTROINTESTINAL TOLERANCE OF DIVALPROEX SODIUMWILDER BJ; KARAS BJ; PENRY JK et al.1983; NEUROLOGY; ISSN 0028-3878; USA; DA. 1983; VOL. 33; NO 6; PP. 808-811; BIBL. 13 REF.Article

ALBUMIN-BINDING INTERACTIONS OF SODIUM VALPROATEFLEITMAN JS; BRUNI J; PERRIN JH et al.1980; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1980; VOL. 20; NO 8-9; PP. 514-517; BIBL. 12 REF.Article

STEADY-STATE KINETICS OF VALPROIC ACID IN EPILEPTIC PATIENTSBRUNI J; WILDER BJ; WILLMORE LJ et al.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 24; NO 3; PP. 324-332; BIBL. 36 REF.Article

VALPROIC ACID: INTERACTION WITH OTHER ANTICONVULSANT DRUGSWILDER BJ; WILLMORE LJ; BRUNI J et al.1978; NEUROLOGY; USA; DA. 1978; VOL. 28; NO 9 PART. 1; PP. 892-896; BIBL. 19 REF.Article

VALPROATE TREMORSPHARM BJK; WILDER BJ; HAMMOND EJ et al.1982; NEUROLOGY; ISSN 0028-3878; USA; DA. 1982; VOL. 32; NO 4; PP. 428-432; BIBL. 20 REF.Article

INTERACTIONS OF VALPROIC ACID WITH PHENYTOINBRUNI J; GALLO JM; LEE CS et al.1980; NEUROLOGY; ISSN 0028-3878; USA; DA. 1980; VOL. 30; NO 11; PP. 1233-1236; BIBL. 15 REF.Article

VALPROIC ACIDS AND PLASMA LEVELS OF PHENOBARBITALBRUNI J; WILDER BJ; PERCHALSKI RJ et al.1980; NEUROLOGY; USA; DA. 1980; VOL. 30; NO 1; PP. 94-97; BIBL. 21 REF.Article

SIMULTANEOUS DETERMINATION OF THE ANTICONVULSANTS, CINROMIDE (3-BROMO-N-ETHYLCINNAMAMIDE), 3-BROMOCINNAMAMIDE, AND CARBAMAZEPINE IN PLASMA BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYPERCHALSKI RJ; BRUNI J; WILDER BJ et al.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 163; NO 2; PP. 187-193; BIBL. 4 REF.Article

HEMATOLOGIC EFFECTS OF PHENYTOIN THERAPY DURING PREGNANCYSTRAUSS RG; RAMSAY RE; WILLMORE LJ et al.1978; OBSTETR. AND GYNECOL.; USA; DA. 1978; VOL. 51; NO 6; PP. 682-685; BIBL. 24 REF.Article